CBIO
Crescent Biopharma, Inc.
14.80$
+1.6%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.0% | 97.5% | 95.6% | 98.9% | 98.8% | 96.8% | 96.8% | 96.2% | 97.9% | 96.6% | 97.7% | 98.5% | |
| 96.4% | 96.6% | 94.5% | 96.4% | 97.7% | 94.2% | 95.9% | 95.7% | 92.4% | 92.2% | 97.6% | 88.7% | |
| 96.4% | 96.6% | 94.5% | 96.4% | 97.7% | 94.2% | 95.9% | 95.7% | 92.4% | 92.2% | 97.6% | 88.7% | |
| 0.0% | 0.1% | 0.6% | 0.1% | 0.2% | 0.1% | 0.0% | 0.0% | 0.3% | 0.4% | 0.4% | 7.5% | |
| 0.0% | – | 0.5% | – | 0.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | 2.0% | |
| 11.3% | 16.5% | 16.7% | 6.9% | 4.4% | 8.2% | 10.2% | 13.5% | 17.1% | 15.2% | 143.5% | 15.5% | |
| 11.3% | 16.0% | 14.9% | 6.4% | 4.1% | 6.5% | 8.7% | 12.5% | 17.1% | 15.1% | 27.0% | 15.0% | |
| – | – | – | – | – | 0.5% | 0.6% | 1.1% | 1.8% | 1.6% | 0.2% | 0.2% | |
| 1.5% | 1.2% | 3.7% | 2.1% | 1.2% | 0.9% | 1.5% | 2.2% | 1.9% | 1.9% | 0.3% | 4.2% | |
| – | – | – | – | – | – | – | – | – | – | 105.2% | – | |
| 88.7% | 83.5% | 83.3% | 93.1% | 95.6% | 91.8% | 89.8% | 86.5% | 82.9% | 84.8% | -43.5% | 84.5% | |
| -129.9% | -179.9% | -280.7% | -118.4% | -93.3% | -153.9% | -216.7% | -395.2% | -809.8% | -1,007.3% | -50.2% | -71.5% | |
| 0.3% | 0.4% | 0.5% | 0.2% | 0.2% | 0.3% | 0.3% | 0.5% | 1.0% | 1.4% | 2.2% | 4.3% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.